IP Library Granted Patent US 12,076,554
Granted Patent B2
US 12,076,554 · App. 17/854,078 · Granted Sep 3, 2024

Penetration of cerebral spinal fluid into the brain parenchyma using temporally patterned neuromodulation

Inventors: Kip Ludwig (Middleton, WI); Justin Williams (Cambridge, WI); Angela Williams (Cambridge, WI); Samuel Poore (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
A61N1/0548A61N1/0432A61N1/36025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,554
App. No.
17/854,078
Granted
Sep 3, 2024
Kind
B2
Abstract

Electrical stimulation of specific facial and lingual nerves creates a more sustained pulsatility activity compared to stimulation of other cranial nerves. Pulsatility of arteries has intrinsic time constraints related to the time for vasodilation/constriction and time to return to baseline (T BL ) after electrical stimulation which may affect the pulsatility response. Control of temporal patterning and the stimulation waveform maximizes the physiological response to cerebral pulsatility and its resulting effects on cerebral spinal fluid penetration into the brain parenchyma for a multitude of therapeutic uses including clearing misfolded proteins and/or administered pharmacological agents, diluting endogenous neurochemical concentrations within the brain, and reducing non-synaptic coupling.

Claims (40)

1. An electrical stimulation device for improving waste

clearance through a perivascular system comprising:

an intraoral device receivable within a human mouth;

at least one electrode supported by the intraoral device configured to stimulate a facial nerve;

an electrical generator generating a carrier wave delivered to the at least one electrode having a carrier frequency, the electrical generator stimulating the perivascular system into increased CSF and ISF flow; and

at least one sensor attached to the intraoral device configured to detect biomarkers within the human mouth indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow.

2. The electrical stimulation device of claim 1 wherein the biomarkers are analytes of tissue or saliva.

3. The electrical stimulation device of claim 2 wherein the analytes are at least one of amyloid beta peptide, tau protein, lactoferrin, alpha-synuclein, DJ-1 protein, chromogranin A, huntingtin protein, DNA methylation disruptions, and micro-RNA profiles.

4. The electrical stimulation device of claim 2 wherein the at least one sensor is configured to detect increased levels of neuronal cytokines.

5. The electrical stimulation device of claim 1 wherein the biomarkers are at least one of a brain wave frequency and heart rate further indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow.

6. The electrical stimulation device of claim 5 wherein the at least one electrode is configured to detect changes in low brain wave frequency.

7. The electrical stimulation device of claim 1 wherein the at least one electrode is adapted to stimulate at least one of a trigeminal nerve, buccal branch nerve, mental branch nerve and facial branch nerve.

8. The electrical stimulation device of claim 1 wherein the intraoral device is a mouthpiece configured to engage a jaw of a user's mouth.

9. An electrical stimulation device for improving waste clearance through a perivascular system comprising:

an intraoral device receivable within a human mouth;

at least one electrode supported by the intraoral device configured to stimulate a facial nerve;

an electrical generator generating a carrier wave delivered to the at least one electrode having a carrier frequency, the electrical generator stimulating the perivascular system into increased CSF and ISF flow; and

at least one sensor supported by the intraoral device configured to detect biomarkers indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow;

wherein the intraoral device is a dental filling configured to be inserted within a cavity of a tooth.

10. An electrical stimulation device for improving waste clearance through a perivascular system comprising:

an intraoral device receivable within a human mouth;

at least one electrode supported by the intraoral device configured to stimulate a facial nerve;

an electrical generator generating a carrier wave delivered to the at least one electrode having a carrier frequency, the electrical generator stimulating the perivascular system into increased CSF and ISF flow;

at least one sensor supported by the intraoral device configured to detect biomarkers indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow;

an electrical modulation generator configured to generate a modulation wave having a predetermined periodicity providing a first period of stimulation of the perivascular system and a second period of relaxation of the perivascular system, the predetermined periodicity selected to increase pulsatility over continuous stimulation of the perivascular system by the carrier frequency; and

a modulator receiving the carrier wave and the modulation wave and modulating the carrier wave for application to the at least one electrode.

11. A method of improving waste clearance through a perivascular system comprising:

positioning at least one electrode supported by an intraoral device in close proximity to a facial nerve;

generating a carrier wave having a carrier frequency stimulating the perivascular system into increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow;

applying the carrier wave to the at least one electrode; and

detecting biomarkers indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow.

12. The method of claim 11 wherein the biomarkers are analytes of tissue or saliva.

13. The method of claim 12 wherein the analytes are at least one of amyloid beta peptide, tau protein, lactoferrin, alpha-synuclein, DJ-1 protein, chromogranin A, huntingtin protein, DNA methylation disruptions, and micro-RNA profiles.

14. The method of claim 12 wherein the at least one sensor is configured to detect increased levels of neuronal cytokines.

15. The method of claim 11 wherein the biomarkers are at least one of a brain wave frequency and heart rate further indicating an increased cerebral spinal fluid (CSF) and interstitial fluid (ISF) flow.

16. The method of claim 15 wherein the at least one electrode is configured to detect changes in low brain wave frequency.

17. The method of claim 11 wherein the facial nerve is at least one of a trigeminal nerve, buccal branch nerve, mental branch nerve and facial branch nerve.

18. The method of claim 11 further comprising

generating a modulation wave having a predetermined periodicity providing a first period of stimulation of the perivascular system and a second period of relaxation of the perivascular system, the predetermined periodicity selected to increase waste clearance over continuous stimulation of the perivascular system by the carrier frequency; and

modulating the carrier wave.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2022
From: LUDWIG, KIP; WILLIAMS, ANGELA; WILLIAMS, JUSTIN; POORE, SAMUEL
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 060406/0935 →
Continuity (3)
Continuation 16935386 · Jul 22, 2020
Provisional Application 62884002 · Aug 7, 2019
Related Publication 20220331583A1 · Oct 20, 2022